Systematic review2023Industry fundedOpen access

Funded in part by General Mills

The Relationship between Whole-Grain Intake and Measures of Cognitive Decline, Mood, and Anxiety-A Systematic Review

Ross AB, Shertukde SP, Livingston Staffier K, Chung M, Jacques PF, McKeown NM

Advances in nutrition (Bethesda, Md.) · 26 citations

Review labels

Author industry tiesIndustry funded

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Systematic review (indexed by PubMed)
Studied in
People
Main outcome
Health markers and function
Intake measured by
Not stated

Who paid for it

Funding
Industry funded
Company
General Mills
Authors
At least one author declares a financial tie to industry

Based on 1 listed funder(s) and full-text disclosure statement.

Publication

Published
2023-04-19 · Adv Nutr · vol. 14 · issue 4 · pp. 652–670
Publisher
Elsevier BV
Cited
40 citations · more than 92% of similar papers · 2.5× the field average
Impact
Top 10% most cited in its field
References
111 works
Access
Open access (hybrid journal) · CC-BY-NC-ND
Research areas
Nutritional Studies and Diet · Consumer Attitudes and Food Labeling · Obesity, Physical Activity, Diet
Keywords
Mood, Observational study, Anxiety, Medicine, Randomized controlled trial, Cognition, Cognitive decline, Systematic review, Cohort study, Depression (economics), Clinical psychology, Psychiatry, MEDLINE, Disease, Internal medicine, Dementia
MeSH
humans, cardiovascular diseases, diabetes mellitus, type 2, anxiety, whole grains, cognitive dysfunction

6 authors

From NZ, US

  • Alastair B. Ross · correspondingAgResearch
  • Shruti P. ShertukdeTufts University
  • Kara A. LivingstonTufts University; Jean Mayer Human Nutrition Research Center on Aging
  • Mei Chun ChungTufts University
  • Paul F. JacquesTufts University; Jean Mayer Human Nutrition Research Center on Aging
  • Nicola Mary McKeownBoston University; Tufts University

Abstract

Greater intake of whole grains, compared to refined grains, is consistently associated with a reduced risk of cardiovascular disease and type 2 diabetes, both of which are associated with cognitive decline. To better understand the relationship between whole-grain intake, cognition, mood, and anxiety, a systematic review was conducted to synthesize available evidence linking whole grains to these outcomes. Four electronic databases were searched from inception to August 2021 for potentially relevant observational and interventional studies. Risk of bias (RoB) assessments were performed using the newly developed Nutrition Quality Evaluation Strengthening Tools, and the Grades of Recommendation, Assessment, Development, and Evaluation approach was used to determine the strength of evidence for each outcome. In total, 23 studies [4 randomized controlled trials (RCTs) and 19 observational studies] met the predefined eligibility criteria. Of these,12 studies included analysis of whole-grain intake and cognitive decline, 9 included mood outcomes, and 2 included both cognition and mood outcomes. The overall evidence for an association between whole-grain intake and cognition is inconclusive. With respect to mood outcomes, evidence from RCTs prospective cohort and case-control studies suggest that higher intake is linked to improved outcomes for mood and depression although the evidence is mixed for cross-sectional studies. Reporting of whole-grain intake fell short of suggested standards, and the strength of available evidence was low or very low for all outcomes. A high RoB toward studies reporting results was also noted, complicating both the interpretation of some studies and the combined evidence. Of note, few well-designed RCTs assessing the effect of whole-grain intake on measures of cognition, mood, and anxiety were identified, highlighting the need for more studies in this area. The available, although limited, evidence suggests that greater whole-grain intake is associated with better mood and anxiety-related scores and is inconclusive regarding cognitive outcomes. PROSPERO registration: CRD42021266355.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC-ND).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.